We've found
45,497
archived clinical trials in
Breast Cancer
We've found
45,497
archived clinical trials in
Breast Cancer
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
Updated: 12/31/1969
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated: 12/31/1969
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
Updated: 12/31/1969
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
Updated: 12/31/1969
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated: 12/31/1969
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
Updated: 12/31/1969
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
Updated: 12/31/1969
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated: 12/31/1969
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
Updated: 12/31/1969
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
Updated: 12/31/1969
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated: 12/31/1969
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
Updated: 12/31/1969
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
Updated: 12/31/1969
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated: 12/31/1969
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
Updated: 12/31/1969
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Comparison of the Philips MicroDose Tomosynthesis System to 2D Digital Mammography
Updated: 12/31/1969
Comparison of the Philips MicroDose Tomosynthesis System to 2D Digital Mammography
Status: Enrolling
Updated: 12/31/1969
Comparison of the Philips MicroDose Tomosynthesis System to 2D Digital Mammography
Updated: 12/31/1969
Comparison of the Philips MicroDose Tomosynthesis System to 2D Digital Mammography
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Preoperative Herceptin and Navelbine for Breast Cancer
Updated: 12/31/1969
Preoperative Herceptin and Navelbine in Early Stage, HER-2 Positive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Preoperative Herceptin and Navelbine for Breast Cancer
Updated: 12/31/1969
Preoperative Herceptin and Navelbine in Early Stage, HER-2 Positive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Preoperative Herceptin and Navelbine for Breast Cancer
Updated: 12/31/1969
Preoperative Herceptin and Navelbine in Early Stage, HER-2 Positive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Preoperative Herceptin and Navelbine for Breast Cancer
Updated: 12/31/1969
Preoperative Herceptin and Navelbine in Early Stage, HER-2 Positive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Preoperative Herceptin and Navelbine for Breast Cancer
Updated: 12/31/1969
Preoperative Herceptin and Navelbine in Early Stage, HER-2 Positive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Preoperative Herceptin and Navelbine for Breast Cancer
Updated: 12/31/1969
Preoperative Herceptin and Navelbine in Early Stage, HER-2 Positive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer
Updated: 12/31/1969
Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer
Updated: 12/31/1969
Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Food Effect Study of D-0502 Tablet in Healthy Volunteers
Updated: 12/31/1969
A Phase I, Randomized, Open Label, Two-Sequence, Two-Period Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of D-0502 Tablet in Postmenopausal Female Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Food Effect Study of D-0502 Tablet in Healthy Volunteers
Updated: 12/31/1969
A Phase I, Randomized, Open Label, Two-Sequence, Two-Period Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of D-0502 Tablet in Postmenopausal Female Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
Updated: 12/31/1969
An Exploratory Study to Identify Potential Surrogate Endpoint Biomarkers That Are Modulated by Tamoxifen vs. Placebo in Women With an Increased Risk for Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
Updated: 12/31/1969
An Exploratory Study to Identify Potential Surrogate Endpoint Biomarkers That Are Modulated by Tamoxifen vs. Placebo in Women With an Increased Risk for Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
Updated: 12/31/1969
An Exploratory Study to Identify Potential Surrogate Endpoint Biomarkers That Are Modulated by Tamoxifen vs. Placebo in Women With an Increased Risk for Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
Updated: 12/31/1969
An Exploratory Study to Identify Potential Surrogate Endpoint Biomarkers That Are Modulated by Tamoxifen vs. Placebo in Women With an Increased Risk for Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
Updated: 12/31/1969
An Exploratory Study to Identify Potential Surrogate Endpoint Biomarkers That Are Modulated by Tamoxifen vs. Placebo in Women With an Increased Risk for Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
Updated: 12/31/1969
An Exploratory Study to Identify Potential Surrogate Endpoint Biomarkers That Are Modulated by Tamoxifen vs. Placebo in Women With an Increased Risk for Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
Updated: 12/31/1969
An Exploratory Study to Identify Potential Surrogate Endpoint Biomarkers That Are Modulated by Tamoxifen vs. Placebo in Women With an Increased Risk for Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
Updated: 12/31/1969
An Exploratory Study to Identify Potential Surrogate Endpoint Biomarkers That Are Modulated by Tamoxifen vs. Placebo in Women With an Increased Risk for Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Improving Surgical/Medical Oncology Collaboration for Breast Cancer Treatment Planning: Pilot Testing the Impact of Continuing Education and Patient Care Planning
Updated: 12/31/1969
Improving Surgical/Medical Oncology Collaboration for Breast Cancer Treatment Planning: Pilot Testing the Impact of Continuing Education and Patient Care Planning
Status: Enrolling
Updated: 12/31/1969
Improving Surgical/Medical Oncology Collaboration for Breast Cancer Treatment Planning: Pilot Testing the Impact of Continuing Education and Patient Care Planning
Updated: 12/31/1969
Improving Surgical/Medical Oncology Collaboration for Breast Cancer Treatment Planning: Pilot Testing the Impact of Continuing Education and Patient Care Planning
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
Updated: 12/31/1969
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
Updated: 12/31/1969
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
Updated: 12/31/1969
Phase II Study of Cardiac Safety and Tolerability of an Adjuvant Chemotherapy Plus Trastuzumab With Lapatinib in Patients With Resected HER2 + Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
Updated: 12/31/1969
Phase II Study of Cardiac Safety and Tolerability of an Adjuvant Chemotherapy Plus Trastuzumab With Lapatinib in Patients With Resected HER2 + Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effect of Increased Light Exposure on Fatigue in Breast Cancer
Updated: 12/31/1969
Effect of Increased Light Exposure on Fatigue in Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Effect of Increased Light Exposure on Fatigue in Breast Cancer
Updated: 12/31/1969
Effect of Increased Light Exposure on Fatigue in Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Vitamin D Supplementation in Women With DCIS and/or LCIS
Updated: 12/31/1969
An Exploratory Pilot Study of Vitamin D Supplementation in Women With DCIS and/or LCIS
Status: Enrolling
Updated: 12/31/1969
Vitamin D Supplementation in Women With DCIS and/or LCIS
Updated: 12/31/1969
An Exploratory Pilot Study of Vitamin D Supplementation in Women With DCIS and/or LCIS
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)
Updated: 12/31/1969
Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 12/31/1969
Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)
Updated: 12/31/1969
Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neoadjuvant GW572016 to Treat Breast Cancer
Updated: 12/31/1969
A Neoadjuvant Phase II Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients: Biologic Correlative Study
Status: Enrolling
Updated: 12/31/1969
Neoadjuvant GW572016 to Treat Breast Cancer
Updated: 12/31/1969
A Neoadjuvant Phase II Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients: Biologic Correlative Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neoadjuvant GW572016 to Treat Breast Cancer
Updated: 12/31/1969
A Neoadjuvant Phase II Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients: Biologic Correlative Study
Status: Enrolling
Updated: 12/31/1969
Neoadjuvant GW572016 to Treat Breast Cancer
Updated: 12/31/1969
A Neoadjuvant Phase II Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients: Biologic Correlative Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neoadjuvant GW572016 to Treat Breast Cancer
Updated: 12/31/1969
A Neoadjuvant Phase II Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients: Biologic Correlative Study
Status: Enrolling
Updated: 12/31/1969
Neoadjuvant GW572016 to Treat Breast Cancer
Updated: 12/31/1969
A Neoadjuvant Phase II Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients: Biologic Correlative Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Sustainable Approach to Increasing Cancer Screening
Updated: 12/31/1969
A Sustainable Approach to Increasing Cancer Screening
Status: Enrolling
Updated: 12/31/1969
A Sustainable Approach to Increasing Cancer Screening
Updated: 12/31/1969
A Sustainable Approach to Increasing Cancer Screening
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer
Updated: 12/31/1969
A Phase II Window of Opportunity Trial of Ipilimumab and Nivolumab in Metastatic Recurrent HER2- Inflammatory Breast Cancer (IBC) The Win Trial
Status: Enrolling
Updated: 12/31/1969
Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer
Updated: 12/31/1969
A Phase II Window of Opportunity Trial of Ipilimumab and Nivolumab in Metastatic Recurrent HER2- Inflammatory Breast Cancer (IBC) The Win Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer
Updated: 12/31/1969
A Phase I Study of a HER-2/Neu Peptide Based Vaccine With GM-CSF as an Adjuvant in Patients With Advanced Stage HER-2/Neu Expressing Cancers
Status: Enrolling
Updated: 12/31/1969
HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer
Updated: 12/31/1969
A Phase I Study of a HER-2/Neu Peptide Based Vaccine With GM-CSF as an Adjuvant in Patients With Advanced Stage HER-2/Neu Expressing Cancers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer
Updated: 12/31/1969
A Phase 1/2 Study of Bcl-2 Antisense Oligonucleotide G3139 in Combination With Doxorubicin and Docetaxel in Metastatic and Locally Advanced Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer
Updated: 12/31/1969
A Phase 1/2 Study of Bcl-2 Antisense Oligonucleotide G3139 in Combination With Doxorubicin and Docetaxel in Metastatic and Locally Advanced Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Metastatic Breast Cancer
Updated: 12/31/1969
A Phase I Trial of a Fixed Dose of MVA-BN-HER2 Following 1st- or 2nd-Line Chemotherapy for HER-2-Positive Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Metastatic Breast Cancer
Updated: 12/31/1969
A Phase I Trial of a Fixed Dose of MVA-BN-HER2 Following 1st- or 2nd-Line Chemotherapy for HER-2-Positive Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Metastatic Breast Cancer
Updated: 12/31/1969
A Phase I Trial of a Fixed Dose of MVA-BN-HER2 Following 1st- or 2nd-Line Chemotherapy for HER-2-Positive Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Metastatic Breast Cancer
Updated: 12/31/1969
A Phase I Trial of a Fixed Dose of MVA-BN-HER2 Following 1st- or 2nd-Line Chemotherapy for HER-2-Positive Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Mindfulness-Enhanced Decision Intervention To Aid Treatment Election - Breast Cancer
Updated: 12/31/1969
The MEDITATE-BC Study: Mindfulness-Enhanced Decision Intervention To Aid Treatment Election - Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Mindfulness-Enhanced Decision Intervention To Aid Treatment Election - Breast Cancer
Updated: 12/31/1969
The MEDITATE-BC Study: Mindfulness-Enhanced Decision Intervention To Aid Treatment Election - Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Partial Breast Irradiation
Updated: 12/31/1969
Phase I/II Partial Breast Irradiation With Concurrent Chemotherapy
Status: Enrolling
Updated: 12/31/1969
Partial Breast Irradiation
Updated: 12/31/1969
Phase I/II Partial Breast Irradiation With Concurrent Chemotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer
Updated: 12/31/1969
A Phase II Study of Simvastatin in Women at High Risk for a New Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer
Updated: 12/31/1969
A Phase II Study of Simvastatin in Women at High Risk for a New Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer
Updated: 12/31/1969
A Phase II Study of Simvastatin in Women at High Risk for a New Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer
Updated: 12/31/1969
A Phase II Study of Simvastatin in Women at High Risk for a New Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
Updated: 2/6/2006
Defining the Interaction of Docetaxel and Lonafarnib in Patients With Advanced Malignancies
Status: Enrolling
Updated: 2/6/2006
Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
Updated: 2/6/2006
Defining the Interaction of Docetaxel and Lonafarnib in Patients With Advanced Malignancies
Status: Enrolling
Updated: 2/6/2006
Click here to add this to my saved trials
Genetic Counseling in African American Women
Updated: 3/21/2007
Genetic Counseling for Breast Cancer Susceptibility in African American Women
Status: Enrolling
Updated: 3/21/2007
Genetic Counseling in African American Women
Updated: 3/21/2007
Genetic Counseling for Breast Cancer Susceptibility in African American Women
Status: Enrolling
Updated: 3/21/2007
Click here to add this to my saved trials
Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study
Updated: 10/23/2007
Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymp Node Positive Breast Cancer: A Pilot Study
Status: Enrolling
Updated: 10/23/2007
Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study
Updated: 10/23/2007
Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymp Node Positive Breast Cancer: A Pilot Study
Status: Enrolling
Updated: 10/23/2007
Click here to add this to my saved trials
Improving Fatigue: A Pilot Study of Acupuncture and Patient Education for Breast Cancer Survivors
Updated: 3/25/2008
Improving Fatigue: A Pilot Study of Acupuncture and Patient Education for Breast Cancer Survivors
Status: Enrolling
Updated: 3/25/2008
Improving Fatigue: A Pilot Study of Acupuncture and Patient Education for Breast Cancer Survivors
Updated: 3/25/2008
Improving Fatigue: A Pilot Study of Acupuncture and Patient Education for Breast Cancer Survivors
Status: Enrolling
Updated: 3/25/2008
Click here to add this to my saved trials
Earlier Breast Cancer Detection Using Automated Whole Breast Ultrasound With Mammography, Including Cost Comparisons
Updated: 3/27/2008
Earlier Breast Cancer Detection Using Automated Whole Breast Ultrasound With Screening Mammography, Including Cost Comparisons
Status: Enrolling
Updated: 3/27/2008
Earlier Breast Cancer Detection Using Automated Whole Breast Ultrasound With Mammography, Including Cost Comparisons
Updated: 3/27/2008
Earlier Breast Cancer Detection Using Automated Whole Breast Ultrasound With Screening Mammography, Including Cost Comparisons
Status: Enrolling
Updated: 3/27/2008
Click here to add this to my saved trials
Peer Counseling for Weight Loss
Updated: 9/4/2008
Peer Counseling for Weight Loss in African American Breast Cancer Survivors
Status: Enrolling
Updated: 9/4/2008
Peer Counseling for Weight Loss
Updated: 9/4/2008
Peer Counseling for Weight Loss in African American Breast Cancer Survivors
Status: Enrolling
Updated: 9/4/2008
Click here to add this to my saved trials
Aromatase Inhibitor Clinical Trial
Updated: 9/24/2008
A Multi-Center Randomized Clinical Trial Correlating the Effects of 24 Months of Exemestane or Letrozole on Surrogate Markers of Response With Aromatase Polymorphism
Status: Enrolling
Updated: 9/24/2008
Aromatase Inhibitor Clinical Trial
Updated: 9/24/2008
A Multi-Center Randomized Clinical Trial Correlating the Effects of 24 Months of Exemestane or Letrozole on Surrogate Markers of Response With Aromatase Polymorphism
Status: Enrolling
Updated: 9/24/2008
Click here to add this to my saved trials
Aromatase Inhibitor Clinical Trial
Updated: 9/24/2008
A Multi-Center Randomized Clinical Trial Correlating the Effects of 24 Months of Exemestane or Letrozole on Surrogate Markers of Response With Aromatase Polymorphism
Status: Enrolling
Updated: 9/24/2008
Aromatase Inhibitor Clinical Trial
Updated: 9/24/2008
A Multi-Center Randomized Clinical Trial Correlating the Effects of 24 Months of Exemestane or Letrozole on Surrogate Markers of Response With Aromatase Polymorphism
Status: Enrolling
Updated: 9/24/2008
Click here to add this to my saved trials
Aromatase Inhibitor Clinical Trial
Updated: 9/24/2008
A Multi-Center Randomized Clinical Trial Correlating the Effects of 24 Months of Exemestane or Letrozole on Surrogate Markers of Response With Aromatase Polymorphism
Status: Enrolling
Updated: 9/24/2008
Aromatase Inhibitor Clinical Trial
Updated: 9/24/2008
A Multi-Center Randomized Clinical Trial Correlating the Effects of 24 Months of Exemestane or Letrozole on Surrogate Markers of Response With Aromatase Polymorphism
Status: Enrolling
Updated: 9/24/2008
Click here to add this to my saved trials
Menopause and Meditation for Breast Cancer Survivors
Updated: 10/13/2008
Menopause and Meditation for Breast Cancer Survivors
Status: Enrolling
Updated: 10/13/2008
Menopause and Meditation for Breast Cancer Survivors
Updated: 10/13/2008
Menopause and Meditation for Breast Cancer Survivors
Status: Enrolling
Updated: 10/13/2008
Click here to add this to my saved trials
Autologous Fat Grafting to the Breast
Updated: 11/17/2008
Autologous Fat Grafting to the Breast
Status: Enrolling
Updated: 11/17/2008
Autologous Fat Grafting to the Breast
Updated: 11/17/2008
Autologous Fat Grafting to the Breast
Status: Enrolling
Updated: 11/17/2008
Click here to add this to my saved trials
Autologous Fat Grafting to the Breast
Updated: 11/17/2008
Autologous Fat Grafting to the Breast
Status: Enrolling
Updated: 11/17/2008
Autologous Fat Grafting to the Breast
Updated: 11/17/2008
Autologous Fat Grafting to the Breast
Status: Enrolling
Updated: 11/17/2008
Click here to add this to my saved trials
Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women
Updated: 12/15/2008
Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women.
Status: Enrolling
Updated: 12/15/2008
Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women
Updated: 12/15/2008
Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women.
Status: Enrolling
Updated: 12/15/2008
Click here to add this to my saved trials
Healing Touch and Health-Related Quality of Life in Women With Breast Cancer Receiving Radiation Therapy
Updated: 1/20/2009
Healing Touch and Health-Related Quality of Life in Women With Breast Cancer in Women With Breast Cancer Receiving Radiation Therapy
Status: Enrolling
Updated: 1/20/2009
Healing Touch and Health-Related Quality of Life in Women With Breast Cancer Receiving Radiation Therapy
Updated: 1/20/2009
Healing Touch and Health-Related Quality of Life in Women With Breast Cancer in Women With Breast Cancer Receiving Radiation Therapy
Status: Enrolling
Updated: 1/20/2009
Click here to add this to my saved trials
Mammosite Breast Brachytherapy Optimization in the Treatment of Breast Carcinoma
Updated: 4/28/2009
A Phase II Trial of Mammosite Breast Brachytherapy Optimization in the Treatment of Stage 0, I and II Breast Carcinoma
Status: Enrolling
Updated: 4/28/2009
Mammosite Breast Brachytherapy Optimization in the Treatment of Breast Carcinoma
Updated: 4/28/2009
A Phase II Trial of Mammosite Breast Brachytherapy Optimization in the Treatment of Stage 0, I and II Breast Carcinoma
Status: Enrolling
Updated: 4/28/2009
Click here to add this to my saved trials
A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer
Updated: 6/5/2009
A Phase II Study of Rapamycin (Rapamune, Sirolimus) and Trastuzumab (Herceptin) for Patients With HER-2 Receptor Positive Metastatic Breast Cancer
Status: Enrolling
Updated: 6/5/2009
A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer
Updated: 6/5/2009
A Phase II Study of Rapamycin (Rapamune, Sirolimus) and Trastuzumab (Herceptin) for Patients With HER-2 Receptor Positive Metastatic Breast Cancer
Status: Enrolling
Updated: 6/5/2009
Click here to add this to my saved trials